Status: Recruiting
Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy
Evaluating the Optimal Effective Dose and Safety of Conbercept in Treating Retinopathy of Prematurity (ROP)
Participants needed: 146
Trial details
Biological sex: AllType: InterventionalSponsor: Wang YushengUpdated: Apr 4, 2025Locations: 3
Eligibility criteria
Preterm infants with less than or equal to 2000 grams of birth weight or less th... [+4]
Preterm infants with stage 4 or 5 ROP in one or both eyes [+9]